ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,073,000 | +87.0% | 221,937 | +26.5% | 0.01% | +66.7% |
| Q4 2018 | $2,178,000 | -66.7% | 175,399 | -48.6% | 0.00% | -25.0% |
| Q3 2018 | $6,546,000 | +189.0% | 341,428 | +105.0% | 0.00% | +33.3% |
| Q2 2018 | $2,265,000 | +802.4% | 166,523 | +22.7% | 0.00% | – |
| Q1 2017 | $251,000 | +43.4% | 135,684 | +20.5% | 0.00% | – |
| Q4 2016 | $175,000 | -75.0% | 112,642 | +18.0% | 0.00% | -100.0% |
| Q3 2016 | $701,000 | +45.7% | 95,441 | +5.6% | 0.00% | 0.0% |
| Q2 2016 | $481,000 | – | 90,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |